What is the appropriate sildenafil dosing based on a patient's creatinine clearance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Sildenafil Dosing in Renal Impairment

For patients with mild to moderate renal impairment (creatinine clearance 30-49 mL/min), no dose adjustment of sildenafil is required; however, for severe renal impairment (creatinine clearance <30 mL/min), start with 25 mg and monitor closely due to approximately doubled drug exposure.

Dosing Algorithm Based on Creatinine Clearance

Normal to Mild Renal Impairment (CrCl ≥50 mL/min)

  • Standard dosing: 50 mg as needed for erectile dysfunction, or 20 mg three times daily for pulmonary arterial hypertension 1
  • No adjustment necessary 1, 2

Moderate Renal Impairment (CrCl 30-49 mL/min)

  • No dose adjustment required 1, 2
  • Pharmacokinetic studies show sildenafil clearance is not significantly altered in this range 2

Severe Renal Impairment (CrCl <30 mL/min)

  • Reduce starting dose to 25 mg 2
  • Sildenafil clearance is reduced by approximately 50%, resulting in:
    • Doubling of AUC and Cmax for parent drug 1, 2
    • 200% increase in metabolite AUC and 79% increase in metabolite Cmax 1
  • Titrate cautiously based on response and tolerability

End-Stage Renal Disease (ESRD) on Hemodialysis

  • Start with 25-50 mg 3, 4, 5
  • Hemodialysis does not clear sildenafil - the drug is 96% protein-bound and not removed by dialysis 6
  • Timing relative to dialysis is not clinically significant (only 17% difference in peak concentration) 6
  • Studies demonstrate 60-85% efficacy in dialysis patients 3, 4, 5

Key Pharmacokinetic Considerations

Protein Binding: Sildenafil is approximately 96% bound to plasma proteins, which is independent of renal function 1. This high protein binding prevents removal by dialysis 6.

Metabolite Accumulation: The active N-desmethyl metabolite (UK-103,320) accumulates more significantly than the parent drug in severe renal impairment, with 200% higher AUC 1, 2. This metabolite has approximately 50% of sildenafil's potency but accounts for about 20% of total pharmacologic effects 1.

Half-life: Terminal half-life remains approximately 4 hours regardless of renal function 1, though systemic exposure increases substantially.

Safety Profile in Renal Impairment

Clinical studies in dialysis patients demonstrate:

  • Well-tolerated with predominantly mild side effects 3, 4, 5
  • Most common adverse effects: headache (18%), flushing (30%) 4
  • No increased risk of intradialytic hypotension 6
  • One case of severe hypotension reported in peritoneal dialysis 4
  • No interaction with immunosuppressants (cyclosporine/tacrolimus levels unchanged in transplant patients) 3

Clinical Pitfalls to Avoid

  1. Do not assume hemodialysis removes sildenafil - timing doses around dialysis is unnecessary 6

  2. Monitor for enhanced effects in severe renal impairment - the doubled drug exposure necessitates starting with lower doses 2

  3. Consider cumulative metabolite effects - the active metabolite accumulates disproportionately in severe renal disease 1

  4. Avoid in patients on nitrates regardless of renal function - this contraindication is absolute 1

  5. Account for age-related changes - elderly patients with renal impairment have additive increases in drug exposure (84% higher AUC from age alone) 2

Special Populations

Renal Transplant Recipients: Sildenafil 25-50 mg is safe and effective, with 60% response rate 3. Better outcomes occur with shorter dialysis duration pre-transplant (mean 23 months in responders vs 43 months in non-responders), likely due to less advanced vascular disease 3.

Peritoneal Dialysis: Same dosing as hemodialysis patients (25-50 mg), with 82% satisfaction rate 4.

References

5
Research

Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction.

Journal of the American Society of Nephrology : JASN, 2002

Related Questions

Can atorvastatin and fenofibrate be prescribed for a patient with impaired renal function (serum creatinine 120 µmol/L, eGFR 48 mL/min/1.73 m²)?
What is the appropriate renal dosing of Compazine (prochlorperazine) for a patient with a creatinine clearance of 20 mL/min?
In a 76-year-old male with impaired renal function (elevated BUN, elevated creatinine, eGFR approximately 15 mL/min) and hypertension who is taking diltiazem 180 mg daily, with blood pressure still mildly elevated at 142/60 mm Hg, what is the safest antihypertensive medication to add?
What are the contraindications to initiating tadalafil (Cialis) or sildenafil (Viagra) in a patient with end‑stage renal disease?
What is the appropriate dosing of fexofenadine (Allegra) for an adult with a creatinine clearance of 35 mL/min?
What lidocaine dose should be administered with intramuscular ceftriaxone?
What is the most frequent complication of intravesical mitomycin (mitomycin C) therapy?
As a primary care provider, can you interpret this urinalysis showing specific gravity 1.030, pH 5.5, trace leukocyte esterase, trace protein, positive nitrite, 6‑10 white blood cells per high‑power field, visible bacteria, calcium oxalate crystals, and a culture reported as no growth?
What is a partial molar pregnancy?
What is the elimination half-life of nicotine delivered by nicotine gum?
What are the contraindications and dosing recommendations for silodosin (alpha‑blocker) based on creatinine clearance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.